GlaxoSmithKline Augments Antibacterial Franchise With Pliva Purchase
This article was originally published in The Pink Sheet Daily
Executive Summary
$50 mil. acquisition of the Croatian lab that gave Pfizer Zithromax could provide GSK with a successor to Augmentin.